. 2019 Jul 3;11(7):1513. doi: 10.3390/nu11071513

Table 4.

Effect of Gelidium elegans on body composition.

Variables		Test (n = 41)	Placebo (n = 37)	p-Value *
DEXA
Total body mass	Baseline	72.78 ± 12.08	71.64 ± 10.61	0.662
(kg)	12 weeks	71.57 ± 11.90	72.10 ± 10.50	0.836
	Δ_{12 week-baseline}	−1.21 ± 1.66 **	0.46 ± 1.19 **	<0.0001
Total fat mass	Baseline	19.66 ± 3.89	19.76 ± 4.23	0.919
(kg)	12 weeks	19.18 ± 3.80	20.84 ± 4.30	0.075
	Δ_{12 week-baseline}	−0.48 ± 1.06 **	1.08 ± 0.75 **	<0.0001
Lean body mass	Baseline	50.68 ± 11.12	49.48 ± 10.51	0.626
(kg)	12 weeks	49.95 ± 10.91	48.85 ± 10.46	0.652
	Δ_{12 week-baseline}	−0.73 ± 1.65 **	−0.63 ± 1.05**	0.743
Fat CT
Visceral fat	Baseline	99.12 ± 43.75	93.97 ± 43.73	0.605
(cm²)	12 weeks	91.76 ± 38.95	95.42 ± 45.48	0.703
	Δ_{12 week-baseline}	−7.36 ± 21.83 **	1.45 ± 13.53	0.034
Subcutaneous fat	Baseline	191.24 ± 56.72	198.49 ± 64.07	0.598
(cm²)	12 weeks	185.58 ± 54.96	210.12 ± 67.08	0.080
	Δ_{12 week-baseline}	−5.67 ± 19.68	11.63 ± 21.49 **	0.0004
Total abdominal fat	Baseline	290.36 ± 81.59	292.46 ± 81.79	0.910
(cm²)	12 weeks	277.33 ± 75.03	305.54 ± 80.18	0.113
	Δ_{12 week-baseline}	−13.03 ± 27.95 **	13.08 ± 26.51 **	<0.0001

Data are presented as mean ± standard deviation. * p-values were calculated using independent t-test. ** were represented as having p-values <0.05 in the paired t-test for comparison within-group differences.